[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 10, Issue 5 (July 2016) ::
Qom Univ Med Sci J 2016, 10(5): 29-37 Back to browse issues page
Subcloning and Assessment of the Expression of Synthetic Botulinum Neurotoxin Type B Binding Domain (BD/B)
Majid Baradaran 1, Firouz Ebrahimi *2, Shahram Nazarian 1, Abbas Hajizade 1, Yousof Tarverdizadeh 1
1- Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran.
2- Biology Research Center, Faculty of Basic Sciences, Imam Hossein University, Tehran, Iran. , febrhimi@ihu.ac.ir
Abstract:   (930 Views)

Background and Objectives: Botulism syndrome is caused by Clostridium botulinum neurotoxin. This neurotoxin has 7 serotypes, from A to G. The best way to prevent botulism syndrome caused by BoNT/B is immunization with recombinant binding domains of BoNT/B (due to containing sufficient epitopes to stimulate the immune system). In this study, the expression of the BoNT/B binding domain as a candidate vaccine, was investigated.

Methods: At first, the sequence of the BoNT/B binding domain gene was obtained from NCBI website with accession number of EF028399.1. After codon optimization, the gene was synthesized in pUC18 vector. Then, the gene was subcloned in pET32a(+) expression vector that carries an ampicillin selection marker. PCR, enzymatic digestion, and sequencing were used to confirm subcloning accuracy, and E. coli BL21(DE3) was used for the expression analysis. The accuracy of protein expression was evaluated by electrophoresis and western blotting.

Results: PCR reaction, enzymatic digestion, and sequencing confirmed that the gene of interest has been subcloned appropriately in the vector. The expression analysis by SDS-PAGE and subsequently western blotting, showed that the protein of interest is not expressed in the mentioned expression strain.

Conclusion: Although the gene was successfully subcloned in pET32a(+) vector, no significant expression of the gene was observed.

Keywords: Clostridium botulinum, Gene expression, Vaccines, Synthetic.
Full-Text [PDF 954 kb]   (535 Downloads)    
Type of Study: Original Article | Subject: روانشناسی
Received: 2016/07/19 | Accepted: 2016/07/19 | Published: 2016/07/19
Send email to the article author

Add your comments about this article
Your username or Email:

Write the security code in the box >



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Baradaran M, Ebrahimi F, Nazarian S, Hajizade A, Tarverdizadeh Y. Subcloning and Assessment of the Expression of Synthetic Botulinum Neurotoxin Type B Binding Domain (BD/B). Qom Univ Med Sci J . 2016; 10 (5) :29-37
URL: http://journal.muq.ac.ir/article-1-1019-en.html
Volume 10, Issue 5 (July 2016) Back to browse issues page
مجله دانشگاه علوم پزشکی قم Qom University of Medical Sciences Journal
Persian site map - English site map - Created in 0.211 seconds with 809 queries by yektaweb 3525